CO5261512A1 - Metodo y composiciones para el tratamiento de las enfermedades pulmonares - Google Patents

Metodo y composiciones para el tratamiento de las enfermedades pulmonares

Info

Publication number
CO5261512A1
CO5261512A1 CO00083427A CO00083427A CO5261512A1 CO 5261512 A1 CO5261512 A1 CO 5261512A1 CO 00083427 A CO00083427 A CO 00083427A CO 00083427 A CO00083427 A CO 00083427A CO 5261512 A1 CO5261512 A1 CO 5261512A1
Authority
CO
Colombia
Prior art keywords
compositions
treatment
pulmonary diseases
separately
time
Prior art date
Application number
CO00083427A
Other languages
English (en)
Spanish (es)
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5261512A1 publication Critical patent/CO5261512A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO00083427A 1999-11-02 2000-11-02 Metodo y composiciones para el tratamiento de las enfermedades pulmonares CO5261512A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
CO5261512A1 true CO5261512A1 (es) 2003-03-31

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00083427A CO5261512A1 (es) 1999-11-02 2000-11-02 Metodo y composiciones para el tratamiento de las enfermedades pulmonares

Country Status (29)

Country Link
EP (1) EP1225866A4 (zh)
JP (1) JP2003513028A (zh)
KR (1) KR20020057988A (zh)
CN (1) CN1387404A (zh)
AP (1) AP2002002496A0 (zh)
AR (1) AR029189A1 (zh)
AU (1) AU1357501A (zh)
BG (1) BG106748A (zh)
BR (1) BR0015270A (zh)
CA (1) CA2388333A1 (zh)
CO (1) CO5261512A1 (zh)
CZ (1) CZ20021512A3 (zh)
DZ (1) DZ3225A1 (zh)
EA (1) EA200200518A1 (zh)
EC (1) ECSP003747A (zh)
HK (1) HK1049107A1 (zh)
HU (1) HUP0203152A3 (zh)
IL (1) IL149367A0 (zh)
MA (1) MA26841A1 (zh)
MX (1) MXPA02004350A (zh)
NO (1) NO20022057L (zh)
OA (1) OA12076A (zh)
PE (1) PE20011005A1 (zh)
PL (1) PL355261A1 (zh)
SK (1) SK7592002A3 (zh)
TR (1) TR200201211T2 (zh)
TW (1) TWI242431B (zh)
WO (1) WO2001032127A2 (zh)
ZA (1) ZA200203435B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100496607C (zh) * 2001-09-19 2009-06-10 尼科梅德有限责任公司 Nsaid与pde-4抑制剂的并用药物
CA2462525A1 (en) * 2001-10-31 2003-05-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
US20060199789A1 (en) * 2003-03-31 2006-09-07 Kyowa Hakko Kogyo Co., Ltd. medical composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JPWO2006041121A1 (ja) * 2004-10-13 2008-05-15 協和醗酵工業株式会社 慢性皮膚疾患の治療および／または予防剤
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
MY187036A (en) 2010-01-05 2021-08-27 Microdose Therapeutx Inc Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7174794A (en) * 1993-06-18 1995-01-17 Smithkline Beecham Corporation Compounds
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
JP2003513028A (ja) 2003-04-08
SK7592002A3 (en) 2002-11-06
CZ20021512A3 (cs) 2003-04-16
HUP0203152A3 (en) 2004-06-28
DZ3225A1 (fr) 2001-05-10
EA200200518A1 (ru) 2002-10-31
MXPA02004350A (es) 2002-11-07
TWI242431B (en) 2005-11-01
ECSP003747A (es) 2002-05-23
WO2001032127A3 (en) 2001-12-06
KR20020057988A (ko) 2002-07-12
BG106748A (en) 2003-02-28
NO20022057L (no) 2002-06-27
MA26841A1 (fr) 2004-12-20
PL355261A1 (en) 2004-04-05
CN1387404A (zh) 2002-12-25
IL149367A0 (en) 2002-11-10
WO2001032127A2 (en) 2001-05-10
EP1225866A2 (en) 2002-07-31
ZA200203435B (en) 2003-06-25
CA2388333A1 (en) 2001-05-10
AR029189A1 (es) 2003-06-18
AU1357501A (en) 2001-05-14
HUP0203152A2 (hu) 2003-01-28
TR200201211T2 (tr) 2002-08-21
AP2002002496A0 (en) 2002-06-30
NO20022057D0 (no) 2002-04-30
EP1225866A4 (en) 2004-04-21
BR0015270A (pt) 2002-06-18
PE20011005A1 (es) 2001-09-28
OA12076A (en) 2006-05-04
HK1049107A1 (zh) 2003-05-02

Similar Documents

Publication Publication Date Title
BR9715022A (pt) Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
DK0682514T3 (da) Anvendelse af lokalanæstetiske midler til fremstilling af et lægmiddel til behandling af bronchial astma
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
AR039947A1 (es) Formulacion farmaceutica que comprende nicotina
IL172705A0 (en) Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases
ES2250416T3 (es) Estimulante de secreciohn de hormona de crecimiento.
CO4970819A1 (es) Tratamiento de disfuncion sexual femenina en una hembra humana
BR9812484A (pt) Terapia combinada para erradicação de hcv-rna detectável em pacientes com infecção crÈnica por hepatite c
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
DE60213404D1 (de) Verwendung von sulodexid zur behandlung von reizdarm
NO20050718L (no) Topikal behandling av hudsykdommer
DK0563023T3 (da) Anvendelse af vævsfaktor pathway inhibitor til fremstilling af et medikament til anvendelse ved en fremgangsmåde til hæmnin
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
CO5261512A1 (es) Metodo y composiciones para el tratamiento de las enfermedades pulmonares
NO20061184L (no) Fremgangsmater og blandinger for behandling av herpes-infeksjoner
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
ES2124983T3 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
PA8525801A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
DE602004024221D1 (de) Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen
BR0311613A (pt) Métodos para inibição, tratamento ou prevenção de sintomas de atrofia da pele, ou atrofia epitelial ou da mucosa nas mulheres e utilização de composto
NO971453D0 (no) Anvendelse av bradykinin-antagonister for fremstilling av legemidler for behandling av kroniske fibrogenetiske og akutte leversykdommer

Legal Events

Date Code Title Description
FC Application refused